Download PDF

1. Company Snapshot

1.a. Company Description

USANA Health Sciences, Inc.develops, manufactures, and sells science-based nutritional and personal care products.The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products.


It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups.In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products.It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online.


The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau.USANA Health Sciences, Inc.was founded in 1992 and is headquartered in Salt Lake City, Utah.

Show Full description

1.b. Last Insights on USNA

The recent 3-month performance of USANA Health Sciences, Inc. was negatively impacted by a lack of significant earnings growth, despite beating Q4 earnings estimates. The company's Q4 2024 earnings release showed a decline in earnings per share to $0.64, compared to $0.87 a year ago. Additionally, the absence of any notable product launches or significant business developments during this period may have contributed to the negative sentiment.

1.c. Company Highlights

2. USANA Health Sciences' Q4 and FY2025 Results Exceed Expectations

USANA Health Sciences reported a strong fourth quarter and fiscal year 2025 results, with consolidated net sales growth driven by the company's strategic pillars: scientific excellence, operational discipline, and a high-performing global sales force. The company's actual EPS came out at $0.6, beating estimates of $0.41. The revenue growth was supported by the company's initiatives to strengthen its global brand positioning, enhance customer and brand partner experiences, and advance product innovation. For fiscal 2026, the company expects net sales growth of 4% at the midpoint. The effective tax rate is expected to be between 55% and 60%, which will be influenced by the geographic misalignment between the revenue generated and the costs incurred.

Publication Date: Mar -09

📋 Highlights
  • 2026 Sales Growth Outlook:: Midpoint guidance of 4% consolidated net sales growth for fiscal 2026, driven by ventures Rise Wellness and Hiya.
  • Inventory Increase:: Inventory rose $35 million (48%) to $107 million by Q4 2025, supporting growth initiatives at Rise Wellness and Hiya.
  • Cost Realignment Impact:: 10% workforce reduction in Q4 fiscal 2025 generated $10 million in savings, allocated to SG&A expenses.
  • Tax Rate Guidance:: Effective tax rate projected at 55-60% for 2026 due to geographic revenue-cost misalignment.
  • Rise Wellness Breakeven:: Anticipates Rise Wellness to operate at breakeven in 2026, with thinner margins impacting gross profit.

Operational Highlights and Guidance

The company's operating strategy for 2026 includes expanding omnichannel reach, advancing product innovation, and accelerating technology modernization. The growth is expected to be driven by venture companies Rise Wellness and Hiya, with Rise Wellness expected to operate at approximately breakeven. The company is working on technology initiatives to enhance customer interaction with its brand, focusing on speed to market and leveraging outside resources. The goal is to stay relevant in the market and drive growth through technology.

Valuation and Outlook

The company's valuation metrics indicate a relatively stable position, with a P/E Ratio of 30.33, P/B Ratio of 0.61, and P/S Ratio of 0.35. The EV/EBITDA ratio is 1.91, and the Free Cash Flow Yield is 5.74%. The ROIC is 2.24%, and the ROE is 2.03%. Analysts estimate next year's revenue growth at 1.9%. The company's net debt to EBITDA ratio is -1.52, indicating a strong cash position. With the company's focus on technology and innovation, it is well-positioned to drive growth in the health and wellness space, which is expected to grow at a CAGR of 5-8%.

Future Plans and Expectations

The company expects a stronger Q1 and Q2, with a lull in Q3 due to summer seasonality, and a return to action in Q4. The cost realignment in the fourth quarter is expected to result in approximately $10 million in savings, which will be primarily used in SG&A. The company is exploring ways to integrate technology into the consumer health management journey, including personalizing nutrition and monitoring health status. It is partnering with other companies to advance this goal with scientific integrity.

3. NewsRoom

Card image cap

Tested, Trusted, Approved: USANA CellSentials Earns ConsumerLab.com Seal of Approval for Purity and Potency

Mar -24

Source: prnewswire.com

Card image cap

USANA Health (USNA) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Mar -10

Source: zacks.com

Card image cap

5 Low P/B Ratio Stocks That You May Consider Buying in March

Mar -06

Source: zacks.com

Card image cap

USANA Health (USNA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Mar -05

Source: zacks.com

Card image cap

4 Value Stocks to Buy as Middle East Tensions Keep Markets on Edge

Mar -05

Source: zacks.com

Card image cap

USANA Looks Like An Undervalued Turnaround Stock

Mar -05

Source: seekingalpha.com

Card image cap

190 USANA-Sponsored Athletes Earn a Record 28 Medals at 2026 Winter Olympic Games

Mar -03

Source: prnewswire.com

Card image cap

USANA Health Sciences to Participate in Upcoming Investor Conferences

Mar -02

Source: businesswire.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (7.96%)

6. Segments

USANA Nutritionals

Expected Growth: 8%

USANA Nutritionals' 8% growth driven by increasing demand for healthy living, expanding online presence, and strategic partnerships. Strong brand recognition, high-quality products, and a large network of independent distributors also contribute to growth. Additionally, the company's focus on innovation, R&D, and geographic expansion into new markets further fuels growth.

USANA Foods

Expected Growth: 7%

USANA Foods' 7% growth driven by increasing demand for healthy and convenient meal options, expansion into new markets, and strategic partnerships. Strong brand recognition, high-quality products, and effective marketing strategies also contribute to growth. Additionally, the rising trend of online shopping and subscription-based services boosts sales.

Personal Care and Skincare

Expected Growth: 9%

USANA Health Sciences, Inc.'s 9% growth in Personal Care and Skincare is driven by increasing demand for natural and organic products, a growing awareness of skin health, and a rising trend of self-care and wellness. Additionally, the company's strong online presence, effective marketing strategies, and expanding product lines have contributed to its growth in this segment.

All Other

Expected Growth: 6%

USANA Health Sciences' 6% growth in All Other segment is driven by increasing demand for nutritional supplements, expansion into new markets, and strategic partnerships. Additionally, the company's focus on e-commerce and digital marketing has improved customer engagement, leading to higher sales. Furthermore, the company's investment in research and development has enabled the launch of new products, contributing to the segment's growth.

7. Detailed Products

Nutritionals

USANA's Nutritionals product line offers a range of dietary supplements that provide essential nutrients, vitamins, and minerals to support overall health and wellness.

Food and Beverages

USANA's Food and Beverages product line includes healthy snack options, beverages, and meal replacement shakes that provide convenient and nutritious solutions for a busy lifestyle.

Skincare and Personal Care

USANA's Skincare and Personal Care product line offers a range of natural and effective skincare products that promote healthy skin, hair, and nails.

Celavive

USANA's Celavive product line is a skincare system that uses InCelligence technology to promote healthy skin and reduce signs of aging.

8. USANA Health Sciences, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

USANA Health Sciences, Inc. has a low threat of substitutes due to its unique and high-quality nutritional supplements, which are difficult to replicate by other companies.

Bargaining Power Of Customers

USANA Health Sciences, Inc. has a medium bargaining power of customers due to the presence of a large customer base, but the company's strong brand loyalty and customer retention programs mitigate this power.

Bargaining Power Of Suppliers

USANA Health Sciences, Inc. has a low bargaining power of suppliers due to its strong relationships with suppliers and its ability to negotiate favorable prices.

Threat Of New Entrants

USANA Health Sciences, Inc. has a medium threat of new entrants due to the presence of barriers to entry, such as high research and development costs and regulatory hurdles, but the company must still be vigilant to new market entrants.

Intensity Of Rivalry

USANA Health Sciences, Inc. operates in a highly competitive industry with many established players, leading to a high intensity of rivalry among companies.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 2.59%
Debt Cost 3.95%
Equity Weight 97.41%
Equity Cost 8.62%
WACC 8.50%
Leverage 2.66%

11. Quality Control: USANA Health Sciences, Inc. passed 5 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Bridgford Foods

A-Score: 5.3/10

Value: 9.8

Growth: 4.0

Quality: 5.1

Yield: 0.0

Momentum: 7.0

Volatility: 5.7

1-Year Total Return ->

View Full Report
Stock-Card
B&G Foods

A-Score: 4.7/10

Value: 9.5

Growth: 2.4

Quality: 2.5

Yield: 10.0

Momentum: 1.0

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
Herbalife Nutrition

A-Score: 4.7/10

Value: 9.0

Growth: 3.6

Quality: 5.8

Yield: 0.0

Momentum: 8.0

Volatility: 2.0

1-Year Total Return ->

View Full Report
Stock-Card
Laird Superfood

A-Score: 3.8/10

Value: 8.7

Growth: 6.9

Quality: 4.9

Yield: 0.0

Momentum: 1.0

Volatility: 1.3

1-Year Total Return ->

View Full Report
Stock-Card
NAI

A-Score: 3.2/10

Value: 9.7

Growth: 2.8

Quality: 2.8

Yield: 0.0

Momentum: 1.0

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
USANA Health Sciences

A-Score: 3.2/10

Value: 7.3

Growth: 2.2

Quality: 5.2

Yield: 0.0

Momentum: 0.0

Volatility: 4.3

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

16.92$

Current Price

16.92$

Potential

-0.00%

Expected Cash-Flows